All Things Considered for December 31, 2022 Hear the All Things Considered program for December 31, 2022

All Things Considered

An older adult receives a COVID-19 vaccine at a temporary vaccination site on Dec. 7 in Chongqing, China. Concerns about effectiveness and safety have led to uncertainty about the COVID vaccine, notably among older citizens, whose vaccination rate is relatively low. He Penglei/China News Service via Getty Images hide caption

toggle caption
He Penglei/China News Service via Getty Images

Goats and Soda

China's COVID vaccines: Do the jabs do the job?

As case counts surge in China, rumors circulate about the effectiveness and safety of the made-in-China vaccines in use there. Here's what we know about CoronaVac and Sinopharm.

An older adult receives a COVID-19 vaccine at a temporary vaccination site on Dec. 7 in Chongqing, China. Concerns about effectiveness and safety have led to uncertainty about the COVID vaccine, notably among older citizens, whose vaccination rate is relatively low. He Penglei/China News Service via Getty Images hide caption

toggle caption
He Penglei/China News Service via Getty Images

China's COVID vaccines: Do the jabs do the job?

  • Download
  • <iframe src="https://www.npr.org/player/embed/1143696652/1146494894" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Searching for a song you heard between stories? We've retired music buttons on these pages. Learn more here.

All Things Considered